Premixed Insulin

DRUG4 trials

Sponsors

Sanofi, Aristotle University Of Thessaloniki, Peking University People's Hospital

Conditions

Diabetes Mellitus, Type 2

Phase 4

Insulin Glargine All to Target Trial

CompletedNCT00384085

SanofiDiabetes Mellitus, Type 2

Start: 2006-05-31End: 2010-03-31Updated: 2011-05-06

Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative Study

CompletedNCT01121835

SanofiDiabetes Mellitus, Type 2

Start: 2010-02-28End: 2012-03-31Updated: 2013-04-04

The Efficacy and Safety of Insulin Degludec/Liraglutide Combination (IDegLira) in Patients With Type 2 Diabetes

Not yet recruitingNCT06408532

Peking University People's HospitalDiabetes Mellitus, Type 2

Start: 2024-04-30End: 2025-02-28Target: 256Updated: 2024-05-10

Unknown Phase

Comparison of Two Biphasic Insulin Regimens

CompletedNCT04726657

Aristotle University Of ThessalonikiDiabetes Mellitus, Type 2

Start: 2016-01-18End: 2020-02-03Updated: 2021-01-27

Related Papers

Greater fear of hypoglycaemia with premixed insulin than with basal-bolus insulin glargine and glulisine: patient-reported outcomes from a 60-week randomised study.

2014-07-127 citations